Analysis of Residual Solvents in Pharmaceuticals - No. 383

Significance of the Topic

Residual solvents in pharmaceutical products can pose toxicity risks and affect drug stability and efficacy. Regulatory guidelines require sensitive and reliable analytical methods for their quantification to ensure patient safety and quality compliance.

Objectives and Study Overview

This study demonstrates a headspace gas chromatography–mass spectrometry method combined with flame ionization detection for simultaneous analysis of 15 common residual solvents in pharmaceutical matrices. Key aims include achieving baseline separation, quantifying low-level analytes and validating method robustness.

Methodology and Instrumentation

• Instrumental setup
  • GC–MS-QP 2020 coupled with HS-20 and FID-2010 Plus
  • Headspace sampling: 1 mL loop, split injection ratio 1:5, constant pressure mode
  • Column: SH-I-624Sil MS (30 m × 0.32 mm I.D., 1.8 µm)
• Headspace parameters
  • Equilibration: 45 min at 80 °C
  • Pressurization: 2 min at 76.4 kPa
  • Injection: 0.5 min with 15 min needle flush
• Oven temperature program
  • 40 °C hold 20 min, ramp 10 °C/min to 240 °C, hold 20 min
• Carrier gas: Helium at constant pressure 89.4 kPa
• FID conditions: 250 °C, make-up flow 30 mL/min, H₂ 40 mL/min, air 400 mL/min
• MS conditions: Ion source 200 °C, interface 250 °C, scan range m/z 29–250, event time 0.3 s

Main Results and Discussion

The method achieved complete resolution of all 15 solvents within a 28-minute run. Limits of detection for critical solvents such as methylene chloride and toluene were below pharmacopeial thresholds. The combined FID and MS detection enhanced quantitation reliability and selectivity across volatile and semi-volatile analytes.

Benefits and Practical Applications

• High sensitivity and specificity for diverse solvent classes
• Robust quantitation minimizing matrix interferences
• Compliance with ICH Q3C and pharmacopeial standards
• Streamlined workflow for routine quality control and validation

Future Trends and Opportunities

Advances in column phases and detector technologies are expected to further reduce analysis times and improve detection limits. Increased automation of sample preparation and data processing will enhance throughput. Emerging techniques such as two-dimensional GC and high-resolution MS offer expanded solvent profiling capabilities.

Conclusion

The presented HS-GC–MS/FID method provides a comprehensive and reliable approach for residual solvent analysis in pharmaceuticals, ensuring regulatory compliance and safeguarding product quality.

References

• Shimadzu Application News M272, First Edition: Sep. 2022, ERAS-1000-0383